These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6744886)
1. An acute intervention trial: the research nurse coordinator's role. Mullin SM; Warwick S; Akers M; Beecher P; Helminger K; Moses B; Rigby PA; Taplin NE; Werner W; Wettach R Control Clin Trials; 1984 Jun; 5(2):141-56. PubMed ID: 6744886 [TBL] [Abstract][Full Text] [Related]
2. The diabetes control and complications trial (DCCT): the trial coordinator perspective. Report by the DCCT Research Group. Ahern JA; Kruger DF; Gatcomb PM; Petit WA; Tamborlane WV Diabetes Educ; 1989; 15(3):236-41. PubMed ID: 2653757 [TBL] [Abstract][Full Text] [Related]
3. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial. Byington RP; Curb JD; Mattson ME JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051 [TBL] [Abstract][Full Text] [Related]
4. Propranolol in acute myocardial infarction: the MILIS experience. Rude RE; Buja LM; Willerson JT Am J Cardiol; 1986 Apr; 57(12):38F-42F. PubMed ID: 2871744 [TBL] [Abstract][Full Text] [Related]
5. Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS). Roberts R; Braunwald E; Muller JE; Croft C; Gold HK; Hartwell TD; Jaffe AS; Mullin SM; Parker C; Passamani ER Br Heart J; 1988 Oct; 60(4):290-8. PubMed ID: 3056476 [TBL] [Abstract][Full Text] [Related]
6. A controlled trial of GL enzyme in the treatment of acute myocardial infarction. Julian DG; Simpson JM; Cadigan PJ; Petri MC; Hall RJ; Smith RH; Pentecost BL Cardiology; 1988; 75(3):177-83. PubMed ID: 3046747 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542 [TBL] [Abstract][Full Text] [Related]
8. Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course. Croft CH; Rude RE; Gustafson N; Stone PH; Poole WK; Roberts R; Strauss HW; Raabe DS; Thomas LJ; Jaffe AS Circulation; 1986 Jun; 73(6):1281-90. PubMed ID: 3009050 [TBL] [Abstract][Full Text] [Related]
9. The use of hyaluronidase in acute myocardial infarction. Papa LA; Fitzgerald DL; Kauffman JM; Schiff S; Daly SJ; Hurwitz H; Caruso JW; Lowney JD; Corbally F J Am Osteopath Assoc; 1983 Oct; 83(2):128-32. PubMed ID: 6358150 [No Abstract] [Full Text] [Related]
10. Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. Roberts R; Croft C; Gold HK; Hartwell TD; Jaffe AS; Muller JE; Mullin SM; Parker C; Passamani ER; Poole WK N Engl J Med; 1984 Jul; 311(4):218-25. PubMed ID: 6377070 [TBL] [Abstract][Full Text] [Related]
11. Effect of a highly purified hyaluronidase preparation (GL enzyme) on electrocardiographic changes in acute myocardial infarction. Henderson A; Campbell RW; Julian DG Lancet; 1982 Apr; 1(8277):874-6. PubMed ID: 6122100 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronidase therapy for acute myocardial infarction: results of a randomized, blinded, multicenter trial. MILIS Study Group. Am J Cardiol; 1986 Jun; 57(15):1236-43. PubMed ID: 2872794 [TBL] [Abstract][Full Text] [Related]
13. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial. Goldstein S Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840 [TBL] [Abstract][Full Text] [Related]
14. [Results of trials of limiting the size of the focal lesion in myocardial infarct infarct by drugs]. Ruda MIa; Afonskaia NI; Avaliani AG; Vikhert AM; Zysko AP Ter Arkh; 1982; 54(11):29-33. PubMed ID: 6818702 [No Abstract] [Full Text] [Related]
15. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group. Byington RP Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483 [TBL] [Abstract][Full Text] [Related]
16. Assessing efficacy of therapeutic intervention on myocardial infarction process by enzymatic prediction method. Mukherjee D J Indian Med Assoc; 1989 Aug; 87(8):185-7. PubMed ID: 2621361 [TBL] [Abstract][Full Text] [Related]
18. Effects of early administration of a highly purified hyaluronidase preparation (GL enzyme) on myocardial infarct size. Saltissi S; Robinson PS; Coltart DJ; Webb-Peploe MM; Croft DN Lancet; 1982 Apr; 1(8277):867-71. PubMed ID: 6122098 [TBL] [Abstract][Full Text] [Related]
19. The Beta Blocker Heart Attack Trial: recruitment experience. Goldstein S; Byington R Control Clin Trials; 1987 Dec; 8(4 Suppl):79S-85S. PubMed ID: 2894282 [TBL] [Abstract][Full Text] [Related]
20. Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology Institute. Bar FW; Vermeer F; de Zwaan C; Ramentol M; Braat S; Simoons ML; Hermens WT; van der Laarse A; Verheugt FW; Krauss XH Am J Cardiol; 1987 Jan; 59(1):6-13. PubMed ID: 3544782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]